Evidence map›Paper›PMID 22157324›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2012

Systemic antibiotic therapy for chronic osteomyelitis in adults.

Brad Spellberg, Benjamin A Lipsky

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 183 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
183citing papers in PubMed, 6 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02168816 phase2terminatednot on this mapstarted 2014, after this paper: background citation

Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for the Treatment of Diabetic Foot Osteomyelitis (CRO-OSTEOMYELITIS)

TypeinterventionalSponsorLoyola UniversityRan2014 to 2017Enrolled30ConditionsOsteomyelitisArmsIntravenous Antibacterial Agent, Oral Antibacterial Agent
NCT03378427 nacompletednot on this mapstarted 2018, after this paper: background citation

Prospective Cohort Study on Patients With Tedizolid Prolonged Therapy for Orthopedic Device Infections

TypeinterventionalSponsorTourcoing HospitalRan2018 to 2021Enrolled35ConditionsProsthetic Joint InfectionArmsTedizolid Phosphate 200 MG [Sivextro]
3 · Its place in the literature

Who cites it

183 citing papers in PubMed, 6 syntheses or guidelines pooled it, 455 citations in OpenAlex.

  1. Pooled it
  2. Rifampin Based Therapy for Patients With Staphylococcus aureus Native Vertebral Osteomyelitis: A Systematic Review and Meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Pooled it
  3. Pooled it
  4. Osteomyelitis Complicating Sacral Pressure Ulcers: Whether or Not to Treat With Antibiotic Therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Pooled it
  5. Pooled it
  6. Antibiotics for treating chronic osteomyelitis in adults.The Cochrane database of systematic reviews · 2013
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Short or Long Antibiotic Regimens in Orthopedics.The New England journal of medicine · 2026
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

123 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Brad SpellbergDivision of General Internal Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA 90502, USA. bspellberg@labiomed.org
Benjamin A Lipsky
Seattle University · USUniversity of California, Los Angeles · US

Funding

Mechanisms of Als vaccine protection against S. aureusR01AI072052 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI SPELLBERG, BRAD J · 2007 to 2011
$1.8M
NIAID NIH HHS R01 AI072052
6 · The paper itself

Abstract

The standard recommendation for treating chronic osteomyelitis is 6 weeks of parenteral antibiotic therapy. However, oral antibiotics are available that achieve adequate levels in bone, and there are now more published studies of oral than parenteral antibiotic therapy for patients with chronic osteomyelitis. Oral and parenteral therapies achieve similar cure rates; however, oral therapy avoids risks associated with intravenous catheters and is generally less expensive, making it a reasonable choice for osteomyelitis caused by susceptible organisms. Addition of adjunctive rifampin to other antibiotics may improve cure rates. The optimal duration of therapy for chronic osteomyelitis remains uncertain. There is no evidence that antibiotic therapy for >4-6 weeks improves outcomes compared with shorter regimens. In view of concerns about encouraging antibiotic resistance to unnecessarily prolonged treatment, defining the optimal route and duration of antibiotic therapy and the role of surgical debridement in treating chronic osteomyelitis are important, unmet needs.

Indexed as

AdultAnti-Bacterial AgentsChronic DiseaseHumansInjections, IntravenousOsteomyelitisAnti-Bacterial Agents

Identifiers

PMID22157324
PMCPMC3491855
OpenAlexW2124042548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.